Global CRO Reach SCOPE International USA operates as a full-service CRO with 17 offices across the US and Europe and coverage extending to North America and over 30 European countries, presenting a scalable partnership opportunity for pharma, biotech, and medical device clients seeking continental trial execution.

Clinical Footprint Having conducted over 250 clinical trials enrolling more than 65,000 subjects demonstrates proven trial operations, diverse therapeutic experience (women’s health, respiratory, CNS and pain, immunology, hematology/oncology), and a track record that can reduce execution risk for potential sponsors.

Relationship Focus A culture centered on trusted long-term relationships and a people-first approach signals strong account management potential, making SCOPE a compelling partner for sponsors prioritizing reliable collaboration, continuity, and attentive study execution.

Strategic Partnerships Past and ongoing collaborations with clusters and partners (BioRN region and other development partners) indicate proactive ecosystem engagement, which can be leveraged to access regional expertise, co-development opportunities, and accelerated site networks.

North American Leadership With a North American subsidiary based in Pittsburgh and leadership roles in the USA market, there is a targeted path to engage US sponsors seeking local presence, regulatory familiarity, and strategic BD contact points for rapid onboarding and scope expansion.